MPM BioImpact’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.4M Buy
+1,667,272
New +$15.4M 0.84% 35

Other funds holding CRBP

MPM BioImpact's CRBP Position: Q3 2026 in Review

MPM BioImpact opened a new position in Corbus Pharmaceuticals (CRBP) in Q3 2026: 1,667,272 shares worth $11.4M. The stake represents 0.84% of the portfolio and ranks #35 among its holdings.

116 funds tracked by Wall St. Rank hold CRBP as of Q3 2026.

  • MPM BioImpact held 1,667,272 shares of Corbus Pharmaceuticals worth $11.4M as of Q3 2026.
  • Corbus Pharmaceuticals was a new MPM BioImpact position in Q3 2026.
  • Corbus Pharmaceuticals made up 0.84% of MPM BioImpact's portfolio in Q3 2026, its #35 holding.
  • 116 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2026.

Based on MPM BioImpact's 13F filing for Q3 2026, filed 16 Nov 2026.